Bloomberg Cites PHE Alzheimer’s Disease Study
A new attention-grabbing PHE study, commissioned by the Alzheimer’s Association, investigates the potential savings of obtaining an earlier diagnosis. (more…)
Precision’s Edgar, Grosvenor, and Rademacher Guest Authors in Biosimilar Development
In Part 1 of a two-part series, Todd Edgar, Alex Grosvenor, and Kellie Rademacher discuss EU biosimilar policies and their impact on the US approach, with a focus on payer coverage. (more…)
Shafrin Comments on News of Cigna-Express Scripts Merger
Jason Shafrin, senior director at Precision Health Economics, shares his initial thoughts on the merger of Cigna and Express Scripts with NBCNews. (more…)
Schafer Talks United’s Point-of-Sale Rebates With Specialty Pharmacy News
Jeremy Schafer, senior vice president, director, Payer Access Solutions, discusses UnitedHealthcare’s recent announcement to apply rebates at point of sale for its fully insured commercial members. (more…)
Gopalan Talks Copay Accumulator Programs in Market Access Spotlight
Ami Gopalan, vice president, Payer Access Solutions with Precision for Value, discusses copay accumulator programs and their impact on patient deductibles and out-of-pocket costs. (more…)